TFE3 and renal cell carcinoma: Research indicates that patients with TFE3-positive renal cell carcinoma (RCC) are more prone to lymph node and distant metastases, exhibit higher tumor nuclear grades and clinical stages, and demonstrate shorter progression-free survival.